Nalli, C., et al. “Fine Specificity of Anti-beta2glycoprotein I Antibodies in Systemic Autoimmune Diseases Is Mostly Directed Against Domain 1”. Reumatismo, vol. 63, no. 2, June 2011, pp. 91-96, doi:10.4081/reumatismo.2011.91.